share_log

CureVac Analyst Ratings

CureVac Analyst Ratings

CureVac 分析師評級
Benzinga ·  2023/08/21 11:36
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/21/2023 -9.76% B of A Securities $10 → $8 Maintains Underperform
06/08/2023 46.64% SVB Securities → $13 Initiates Coverage On → Outperform
04/26/2023 170.73% JMP Securities $34 → $24 Maintains Outperform
01/19/2023 103.05% UBS → $18 Upgrades Neutral → Buy
01/09/2023 — Jefferies Upgrades Hold → Buy
11/17/2022 283.53% JMP Securities $37 → $34 Maintains Market Outperform
04/22/2022 317.37% JMP Securities $52 → $37 Maintains Market Outperform
01/21/2022 125.61% B of A Securities $55 → $20 Downgrades Neutral → Underperform
01/18/2022 486.58% JMP Securities → $52 Initiates Coverage On → Market Outperform
10/22/2021 294.81% Deutsche Bank → $35 Initiates Coverage On → Hold
06/17/2021 464.02% B of A Securities → $50 Downgrades Buy → Neutral
04/26/2021 — Guggenheim Initiates Coverage On → Buy
12/10/2020 — Credit Suisse Downgrades Neutral → Underperform
09/08/2020 689.62% B of A Securities → $70 Initiates Coverage On → Buy
09/08/2020 554.26% Jefferies → $58 Initiates Coverage On → Hold
09/08/2020 667.06% Credit Suisse → $68 Initiates Coverage On → Neutral
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
08/21/2023 -9.76% B of A 類證券 10 美元 → 8 美元 維護 表現不佳
06/08/2023 46.64% SVB 證券 → 13 美元 啓動覆蓋開啓 → 跑贏大盤
2023 年 4 月 26 日 170.73% JMP 證券 34 美元 → 24 美元 維護 跑贏大盤
01/19/2023 103.05% 瑞銀（UBS） → 18 美元 升級 中性 → 買入
01/09/2023 — 傑富瑞 升級 持有 → 買入
11/17/2022 283.53% JMP 證券 37 美元 → 34 美元 維護 市場表現跑贏大盤
04/22/2022 317.37% JMP 證券 52 美元 → 37 美元 維護 市場表現跑贏大盤
01/21/2022 125.61% B of A 類證券 55 美元 → 20 美元 降級 中性 → 跑贏大盤
01/18/2022 486.58% JMP 證券 → 52 美元 啓動覆蓋開啓 → 市場跑贏大盤
2021 年 10 月 22 日 294.81% 德意志銀行 → 35 美元 啓動覆蓋開啓 → 按住
06/17/2021 464.02% B of A 類證券 → 50 美元 降級 買入 → 中性
04/26/2021 — 古根海姆 啓動覆蓋開啓 → 購買
2020 年 10 月 12 日 — 瑞士信貸 降級 中性 → 跑贏大盤
2020 年 8 月 9 日 689.62% B of A 類證券 → 70 美元 啓動覆蓋開啓 → 購買
2020 年 8 月 9 日 554.26% 傑富瑞 → 58 美元 啓動覆蓋開啓 → 按住
2020 年 8 月 9 日 667.06% 瑞士信貸 → 68 美元 啓動覆蓋開啓 → 中立

What is the target price for CureVac (CVAC)?

CureVac (CVAC) 的目標價格是多少？

The latest price target for CureVac (NASDAQ: CVAC) was reported by B of A Securities on August 21, 2023. The analyst firm set a price target for $8.00 expecting CVAC to fall to within 12 months (a possible -9.76% downside). 6 analyst firms have reported ratings in the last year.

B of A Securities於2023年8月21日公佈了CureVac（納斯達克股票代碼：CVAC）的最新目標股價。該分析公司將目標股價定爲8.00美元，預計CVAC將在12個月內跌至12個月內（可能下跌-9.76％）。去年有6家分析公司公佈了評級。

What is the most recent analyst rating for CureVac (CVAC)?

CureVac (CVAC) 的最新分析師評級是多少？

The latest analyst rating for CureVac (NASDAQ: CVAC) was provided by B of A Securities, and CureVac maintained their underperform rating.

CureVac（納斯達克股票代碼：CVAC）的最新分析師評級由B of A Securities提供，CureVac維持其表現不佳的評級。

When is the next analyst rating going to be posted or updated for CureVac (CVAC)?

CureVac (CVAC) 的下一份分析師評級何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CureVac, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CureVac was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.

分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與CureVac的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。CureVac的最後一次評級是在2023年8月21日提交的，因此你應該預計下一個評級將在2024年8月21日左右公佈。

Is the Analyst Rating CureVac (CVAC) correct?

分析師對CureVac (CVAC) 的評級是否正確？

While ratings are subjective and will change, the latest CureVac (CVAC) rating was a maintained with a price target of $10.00 to $8.00. The current price CureVac (CVAC) is trading at is $8.87, which is out of the analyst's predicted range.

儘管評級是主觀的，並且會發生變化，但最新的CureVac（CVAC）評級保持不變，目標價爲10.00美元至8.00美元。CureVac（CVAC）的當前交易價格爲8.87美元，超出了分析師的預測區間。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論